Menelas N Pangalos has bought ABSI on 3 days since Sep 2025

Prof. Sir Menelas (Mene) Pangalos, Ph.D., age 58, is an independent director (Class II) at Absci Corporation (ABSI) since January 1, 2024, with his term expiring at the 2026 annual meeting.( He holds a Ph.D. in Neurochemistry (or Neuropharmacology) and a B.S. in Biochemistry (or Biochemistry and Molecular Biology) from the University of London institutions including University College London and Imperial College.( Knighted in 2019, he is a Fellow of the Royal Society, Academy of Medical Sciences, Royal Society of Biology, and Clare Hall, Cambridge, and serves as Visiting Professor of Neuroscience at King’s College London since 2005.(

Pangalos brings over three decades of senior R&D leadership in pharmaceuticals, most notably as Executive Vice President of Biopharmaceuticals R&D at AstraZeneca from 2019 to 2024, where he oversaw global R&D operations across 40 sites with a $4 billion budget, transforming productivity with success rates four times the industry average and accelerating drugs like osimertinib to market in 2.5 years.( Previously, he held EVP roles at AstraZeneca since 2010, and senior positions at Pfizer (SVP and CSO Neuroscience, 2009-2010), Wyeth, and GlaxoSmithKline.( He currently serves on the boards of Biogen Inc. (since January 2025, Compensation Committee) and others, post-retirement from AstraZeneca.(

Written by Perplexity from public sources.